Pages that link to "Q85885681"
Jump to navigation
Jump to search
The following pages link to Yoichi Hiasa (Q85885681):
Displaying 50 items.
- Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean (Q28480585) (← links)
- Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan (Q33873646) (← links)
- No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. (Q34308762) (← links)
- Gianotti-Crosti syndrome caused by acute hepatitis B virus genotype D infection (Q34356463) (← links)
- Clinical features of adult patients with acute hepatitis B virus infection progressing to chronic infection. (Q34366249) (← links)
- New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia (Q35092586) (← links)
- Utility of Contrast-Enhanced Transabdominal Ultrasonography to Diagnose Early Chronic Pancreatitis (Q35674396) (← links)
- Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma (Q36367144) (← links)
- Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. (Q37191549) (← links)
- Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection (Q38978208) (← links)
- FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma (Q39297937) (← links)
- Dietary intake habits and the prevalence of nocturia in Japanese patients with type 2 diabetes mellitus. (Q40138645) (← links)
- A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade (Q40154217) (← links)
- Physical activity and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: The Dogo Study. (Q40260761) (← links)
- Tracing the history of hepatitis B virus genotype D in western Japan (Q45422350) (← links)
- Relative changes in handgrip strength and skeletal muscle volume in patients with chronic liver disease over two-year observation period. (Q47556384) (← links)
- Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications (Q47796906) (← links)
- Muscle volume loss a prognostic factor for death in liver cirrhosis patients and special relationship to portal hypertension. (Q48304531) (← links)
- Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis (Q50081492) (← links)
- Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade (Q51672241) (← links)
- Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. (Q52699058) (← links)
- Roles of protein kinase R in cancer: Potential as a therapeutic target. (Q53924963) (← links)
- Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease. (Q55361713) (← links)
- Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with HCV infection (Q58596840) (← links)
- Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis (Q61455444) (← links)
- Effects of Motilin Receptor Agonists and Ghrelin in Human motilin receptor Transgenic Mice (Q64112541) (← links)
- Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation (Q64114887) (← links)
- Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic (Q64134602) (← links)
- Recommendation of lamivudine-to-entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial (Q84129557) (← links)
- Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method (Q88428333) (← links)
- Neutrophil-to-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib (Q89739672) (← links)
- Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib (Q89769449) (← links)
- Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma (Q89878015) (← links)
- Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis (Q90288450) (← links)
- Analysis of 307 cases with drug-induced liver injury between 2010 and 2018 in Japan (Q90631296) (← links)
- Insulin-like growth factor-1 is inversely associated with liver fibrotic markers in patients with type 2 diabetes mellitus (Q90791802) (← links)
- Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching (Q90982789) (← links)
- Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis (Q91136638) (← links)
- Zinc deficiency as an independent prognostic factor for patients with early hepatocellular carcinoma due to hepatitis virus (Q91290772) (← links)
- Prediction of risk of falls based on handgrip strength in chronic liver disease patients living independently (Q91634861) (← links)
- Platelet-lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib: an inverse probability weighting analysis (Q91859511) (← links)
- Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma (Q91891911) (← links)
- SARC-F combined with a simple tool for assessment of muscle abnormalities in outpatients with chronic liver disease (Q91919920) (← links)
- Longitudinal impact of dapagliflozin treatment on ventricular repolarization heterogeneity in patients with type 2 diabetes (Q92030988) (← links)
- Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis (Q92285782) (← links)
- New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode (Q92900970) (← links)
- Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma (Q92986515) (← links)
- Sex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infection (Q94568858) (← links)
- Efficacy of combining electric-field and C-plane imaging to obtain ultrasound-ultrasound fusion images in monopolar radiofrequency ablation for patients with liver cancer (Q95645738) (← links)
- Association between serum bilirubin and mucosal healing among Japanese patients with ulcerative colitis: a cross-sectional study (Q100516291) (← links)